SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
THERAVANCE
(NQNM:THRX Last Sale: 41.19 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (THRX : $41.19)
$2,582 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today

901 Gateway Boulevard Research Report Earnings Snapshot - Last 10/30/18
South San Francisco, CA 94080 Fact Sheet
Phone: 650-808-6000 Financial Statements
Peer Comparison
Annual Reports

Rick E. Winningham, CEO/Pres., Michael W. Aguiar, CFO
IPO at $16 October 4, 2004. Raised $98.4 million, selling 6.15 million shares, 14% of the outstanding. Lead Manager: Merrill Lynch.
Historical Charts    Technical Analysis
No Historical Data available for THRX

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common THRX $41.19 $ 0 $38.5 $41.795 2,524,532 $19.61 $42.9599 62,685
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $2,581,995

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex